Development of a Predictive Model for Post-Discharge Nausea and Vomiting (PDNV)
NCT ID: NCT00514878
Last Updated: 2009-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2000 participants
OBSERVATIONAL
2007-08-31
2008-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Costs of Postoperative Nausea and Vomiting in Ambulatory Surgery Patients
NCT00858949
Predictive Model for PONV for Patient Received Gynecological Laparoscopic Surgery
NCT05757986
The Effect of Combining Aprepitant With Ondansetron in High-risk Patients for Postoperative Nausea and Vomiting
NCT01897337
Continuous Infusion of Palonosetron for Preventing of Postoperative Nausea and Vomiting
NCT01482468
Prevention of Postoperative Nausea and Vomiting (PONV) in Surgical Patients
NCT00757822
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Adult same-day outpatients scheduled for general anesthesia
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled for an elective outpatient surgical procedure
* understands the nature and purpose of this survey and has signed an informed consent form
* willing and able to complete daily components of the Patient Diary from the day of surgery until the end of the 48 hour assessment
* undergoing general anesthesia requiring a tracheal tube or laryngeal mask airway
Exclusion Criteria
* inability to communicate in English
* regional anesthesia alone without general anesthesia, as PONV in this setting is known to be significantly lower \[18, 19\]
* persistent or recurrent nausea and/or vomiting before anesthesia due to other etiologies, unless clearly related only to the anxiety due to impending surgery
* minors (\< 18 years of age)
* current pregnancy by self-report (potentially confounding for etiology of nausea)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merck Sharp & Dohme LLC
INDUSTRY
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of California
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian C Apfel, MD, PhD
Role: STUDY_DIRECTOR
Perioperative Clinical Research Core, University of California San Francisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Perioperative Clinical Research Core, University of California
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H54427-30684
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.